Commercial Aquaculture Vaccines Market

Commercial Aquaculture Vaccines Are Approved Vaccines That Can Induce Protective Immune Responses In Aquatic Animals. The Mass Production Of Aquatic Species Leads To Changes In Optimal Breeding Conditions, Which Indicates Increased Sensitivity To Infectious/Viral Diseases, Thereby Increasing Increased Demand For Commercial Aquaculture Vaccines, Bacterial Diseases And Zoonotic Infections, Are Major Obstacles To Successful Aquaculture. Facts Have Proved That Commercial Aquaculture Vaccines Are A Better Alternative To Antibiotics Used In Fish Aquaculture, Because Antibiotic Treatment Has Attracted A Lot Of Attention Due To Adverse Effects Such As Bacterial Resistance, Toxicity, And Residual Antibiotics In Aquaculture Food. In Addition, The Increase In Global Fish Consumption And The Prevalence Of Bacterial Infections Between Aquatic Species Are Also Increasing The Use Of Commercial Fish Aquaculture Vaccines.

Commercial Aquaculture Vaccines Market contains market size and forecasts of Commercial Aquaculture Vaccines in global, including the following market information:

Global Commercial Aquaculture Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Commercial Aquaculture Vaccines Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Commercial Aquaculture Vaccines companies in 2021 (%)

The global Commercial Aquaculture Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Nucleic Acid Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Commercial Aquaculture Vaccines include Zoetis LLC, Merck & Co. Inc. (MSD Animal Health), Laboratorios Hipra S. A., Elanco Animal Health Inc, Veterquimica S. A., Ictyogroup, Tecnovax and Nisseiken Co Ltd, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Commercial Aquaculture Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Commercial Aquaculture Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Commercial Aquaculture Vaccines Market Segment Percentages, by Type, 2021 (%)

Nucleic Acid Vaccine

Subunit Vaccine

Live Attenuated Vaccine

Inactivated Vaccine

Global Commercial Aquaculture Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Commercial Aquaculture Vaccines Market Segment Percentages, by Application, 2021 (%)

Fisheries

Breeding Clinic

Fisheries Research Institute

Global Commercial Aquaculture Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Commercial Aquaculture Vaccines Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Commercial Aquaculture Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Commercial Aquaculture Vaccines revenues share in global market, 2021 (%)

Key companies Commercial Aquaculture Vaccines sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Commercial Aquaculture Vaccines sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Zoetis LLC

Merck & Co. Inc. (MSD Animal Health)

Laboratorios Hipra S. A.

Elanco Animal Health Inc

Veterquimica S. A.

Ictyogroup

Tecnovax

Nisseiken Co Ltd